Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment [PDF]
core +1 more source
Targeting the p53/xCT/GSH Axis with PRIMA-1<sup>Met</sup> Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia. [PDF]
Pasino M +21 more
europepmc +1 more source
Correction: PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma by Induction of p73 and Noxa [PDF]
openaire +2 more sources
[Corrigendum] PRIMA‑1met induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‑ULK1‑Vps34 signaling cascade. [PDF]
Li XL +5 more
europepmc +1 more source
PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53. [PDF]
Grellety T +6 more
europepmc +1 more source
APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase. [PDF]
Peng X +7 more
europepmc +1 more source
PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma. [PDF]
Paz MM +9 more
europepmc +1 more source
Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET. [PDF]
Shalom-Feuerstein R +8 more
europepmc +1 more source
Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma. [PDF]
Aryee DN +7 more
europepmc +1 more source

